Population-based case-control study: chemoprotection of colorectal cancer with non-aspirin nonsteroidal anti-inflammatory drugs and other drugs for pain control

Glucosamine use and risk of colorectal cancer: results from the Cancer Prevention Study II Nutrition Cohort

(2018) Elizabeth D. Kantor et al.   CANCER CAUSES & CONTROL

Possible role of chondroitin sulphate and glucosamine for primary prevention of colorectal cancer. Results from the MCC-Spain study

(2018) Gemma Ibáñez-Sanz et al.   Scientific Reports

Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial

(2018) J Michael Gaziano et al.   LANCET

Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly

(2018) John J. McNeil et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus

(2018)   NEW ENGLAND JOURNAL OF MEDICINE

Clopidogrel and Low-Dose Aspirin, Alone or Together, Reduce Risk of Colorectal Cancer

(2018) Antonio Rodríguez-Miguel et al.   Clinical Gastroenterology and Hepatology

Advances in antitumor effects of NSAIDs

(2018) Zhen Zhang et al.   Cancer Management and Research

Non-aspirin non-steroidal anti-inflammatory drugs in prevention of colorectal cancer in people aged 40 or older: A systematic review and meta-analysis

(2018) Tanja Tomić et al.   Cancer Epidemiology

Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement

(2016) Kirsten Bibbins-Domingo et al.   ANNALS OF INTERNAL MEDICINE

Use of glucosamine and chondroitin supplements in relation to risk of colorectal cancer: Results from the Nurses' Health Study and Health Professionals follow-up study

(2016) Elizabeth D. Kantor et al.   INTERNATIONAL JOURNAL OF CANCER

Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib

(2015) Marc C Hochberg et al.   ANNALS OF THE RHEUMATIC DISEASES

Chemoprevention of Colorectal Cancer

(2015) Michaela Lang et al.   DIGESTIVE DISEASES

Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries

(2015) Chen Mo   WORLD JOURNAL OF GASTROENTEROLOGY

Oral chondroprotection with nutraceuticals made of chondroitin sulphate plus glucosamine sulphate in osteoarthritis

(2014) Carlo Bottegoni et al.   CARBOHYDRATE POLYMERS

Platelets, Cyclooxygenases, and Colon Cancer

(2014) Paloma Guillem-Llobat et al.   SEMINARS IN ONCOLOGY

Colorectal cancer: From prevention to personalized medicine

(2014) Gemma Binefa   WORLD JOURNAL OF GASTROENTEROLOGY

Use of glucosamine and chondroitin supplements and risk of colorectal cancer

(2013) E. D. Kantor et al.   CANCER CAUSES & CONTROL

NSAIDs Inhibit Tumorigenesis, but How?

(2013) Evrim Gurpinar et al.   CLINICAL CANCER RESEARCH

Colorectal cancer

(2013) Hermann Brenner et al.   LANCET

The role of chemoprevention by selective cyclooxygenase-2 inhibitors in colorectal cancer patients - a population-based study

(2012) Yi-Hsin Yang et al.   BMC CANCER

Missing covariate data in clinical research: when and when not to use the missing-indicator method for analysis

(2012) R. H. H. Groenwold et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Cyclooxygenase as a Target for Colorectal Cancer Chemoprevention

(2011) Leticia Moreira et al.   CURRENT DRUG TARGETS

Associations of Herbal and Specialty Supplements with Lung and Colorectal Cancer Risk in the VITamins And Lifestyle Study

(2009) J. A. Satia et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The role of COX-2 in intestinal inflammation and colorectal cancer

(2009) D Wang et al.   ONCOGENE

Pro-inflammatory prostaglandins and progression of colorectal cancer

(2008) Dingzhi Wang et al.   CANCER LETTERS